![]() | |
Clinical data | |
---|---|
Trade names | Androxan, Neo-Ponden, Neo-Pondus |
Other names | 17α-Methyl-5α-androstano[3,2-c]isoxazol-17β-ol |
Routes of administration | By mouth |
Drug class | Androgen;Anabolic steroid |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C21H31NO2 |
Molar mass | 329.484 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Androisoxazole (brand namesAndroxan,Neo-Ponden,Neo-Pondus), also known as17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol, is anorally activeanabolic-androgenic steroid (AAS) and a17α-alkylatedderivative ofdihydrotestosterone (DHT) that is marketed inSpain andItaly.[1][2][3][4] It is closely related tostanozolol, differing only in having anisoxazole instead ofpyrazolering fused to the A ring,[4] and is also related tofurazabol,prostanozol, anddanazol.
![]() | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |